Malaria has been around longer than humankind. The endgame for this deadly parasitic disease is in sight.
Rigor académico, oficio periodístico
Artículos sobre Malaria vaccine
Mostrando 1 - 20 de 28 artículos
This is an era of exciting advances in medical science. But Africa is in danger of being at the back of the queue once again. What should we be doing to make sure this doesn’t happen?
In this episode of The Conversation Weekly, we hear from the scientists behind a new malaria vaccine developed by the University of Oxford.
After recent cases in Florida and Texas, authorities are advising the public to drain standing water sources to keep mosquitoes from multiplying.
Nigeria must do more to reduce its high malaria burden.
For a malaria vaccine to have an impact, health promotion is key. Awareness campaigns must address safety concerns and emphasise expected positive impacts.
A combination of herbs in Nigeria should be evaluated further as it offers potential to treat malaria, which is endemic in the country.
The successful development of an effective vaccine against the deadliest form of malaria that is most common in sub-Saharan Africa is indeed a major achievement.
Malaria is one of the world’s oldest and deadliest diseases. So why has it taken so long to get a vaccine?
The WHO and the manufacturers of the vaccine will be rallying countries, particularly those with high malaria burdens, to adopt the vaccine.
But the vaccine isn’t perfect. So we’ll still need mosquito nets and insecticides too.
Nigeria must invest more in research and incorporate World Health Organisation-recommended interventions to eliminate malaria.
We have two mRNA COVID-19 vaccines so far. But what else can this technology do?
Genetic diversity of a parasite population might help us watch for drug-resistant parasites.
Coronavirus is a stark reminder of what a world without vaccines would look like.
Deliberately infecting people with a disease-causing agent as part of carefully considered medical research can be ethically acceptable or even necessary.
Given the high burden of malaria in sub-Saharan Africa, a partially effective vaccine is considered better than none.
Researchers have tried unsuccessfully for decades to develop a malaria vaccine. Now a new approach, showing promise in mice, suggests it is possible to block mosquitoes from spreading the disease.
Progress in malaria control has stalled. Research towards an effective vaccine is underway.
Baringo county and other areas on the western side of Kenya are struggling to reduce their seasonal malaria caseloads.
Principales colaboradores
-
Co-Director, Institute of Infection, Chair, Immunology & Vaccinology, Imperial College London
-
Professor in Molecular Parasitology and Genetics, Federal University, Oye Ekiti
-
Project Manager, Cambridge Africa, Anglia Ruskin University
-
Research Chair, Integrated Vector Management in the Vector Control Cluster, Centre for Sustainable Malaria Control, University of Pretoria
-
Director of the Jenner Institute, University of Oxford
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Postdoctoral Research Fellow, Molecular Parasitology, Department of Biochemistry, University of Pretoria
-
Ph.D. Candidate in the Biomedical Engineering Department, University at Buffalo
-
Professor and NHMRC Investigator Fellow, Institute for Glycomics, Griffith University
-
Chief Research Officer, Malaria Branch Chief in the KEMRI, CDC and London School of Tropical Medicine Collaborative Program, Kenya Medical Research Institute
-
Associate Professor (Biochemistry) DST/NRF South African Research Chair (SARChI) in Sustainable Malaria Control, University of Pretoria
-
Associate Professor of Biomedical Engineering, University at Buffalo
-
Medical scientist, National Institute for Communicable Diseases
-
Infectious Disease Ethics Fellow, Ethox & Wellcome Centre for Ethics and Humanities, Univeristy of Oxford. Adjunct, Monash University
